Breaking news

CE-mark for new generation lens system - PreciSight® !

Access to press release. -- English Version
Access to press release. -- French Version

Management Team

Carsten Laue, PhD
Chief Executive Officer

Carsten Laue heads the management team in his role as Chief Executive Officer. Formerly the Chief Executive of a Swiss Contract Research Organization and a researcher at IMD Business School in Lausanne, Switzerland, he brings extensive experience in CE-marking of medical devices, and clinical development.
Dr. Laue holds a PhD from the Swiss Federal Institute of Technology in Lausanne.

Ted P. Werblin, MD, PhD
Inventor and co-founder - Chief Medical Officer

Ted Werblin is a practicing ophthalmic surgeon and associate clinical professor of ophthalmology at the University of Virginia in Charlottesville, USA. Dr Werblin is the inventor of IVO’s intraocular lens technology. He serves as Chief Medical Officer.
He is the author of numerous scientific publications in journals including the Journal of Cataract & Refractive Surgery and the Journal of Refractive Surgery and performs around 500 surgical cases per year.
Dr. Werblin earned his MD and PhD from New York University. He completed his residency in Ophthalmology at Johns Hopkins University, the Wilmer Institute in Baltimore MD. followed by a two year fellowship with Herb Kaufman in Cornea and External Disease at Louisiana State University in New Orleans, LA. He certified by the American Board of Ophthalmology, the National Board of Medical Examiners, and the American Board of Internal Medicine.
Dr. Werblin reviews for the major cataract peer review journals.

Harilaos Ginis, PhD
Head of technical research

Harilaos Ginis is head of the Research department at Athens Eye Hospital and works for the development of novel diagnostic and surgical methods in ophthalmology. His personal research interests include straylight phenomena in vision and optical metrology in the eye. He is in the editorial board as topical editor for Clinical Vision and Visual Optics of the Journal of the Optical Society of America A. (JOSAA) He holds more than ten patents and has designed various devices that are commercial in ophthalmology including surgical systems, diagnostic instruments and intraocular lenses. He worked at the Laboratorio de Optica Murcia (Spain) on imaging and diagnostic applications in ophthalmology, including 2-photon microscopy and in-vivo optical characterization of ocular tissues. Harilaos Ginis received his BSc degree in Physics from the University of Crete in 1993 and worked for three years in the local biomedical industry. He returned to academia and earned his PhD in biomedical technology in 2003.


Remora Partners
Strategic Advisor

Remora Partners is a strategy advisor and investment company for high potential technology small and medium enterprises (SMEs). Remora Partners supports IVO in strategy definition, implementation and investor relation, and provided seed investment to IVO.